Chronic renal disease is associated with stroke and thromboembolism in atrial fibrillation independently from gender

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 3106-3107

  Providência, Rui ^a,b   Barra, Sérgio ^a   Paiva, Luís ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Atrial fibrillation; Death; Female gender; Glomerular filtration rate; Ischemic stroke; Prognosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIVITAMIN K; APIXABAN; BLOOD CLOTTING FACTOR 10A INHIBITOR; CLOPIDOGREL; CYSTATIN; DIGOXIN; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RIVAROXABAN; WARFARIN;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; COMORBIDITY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG UTILIZATION; EMBOLISM; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HUMAN; KIDNEY FUNCTION; LETTER; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; THROMBOEMBOLISM;

ATRIAL FIBRILLATION; DEATH; FEMALE GENDER; GLOMERULAR FILTRATION RATE; ISCHEMIC STROKE; PROGNOSIS;

ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; FEMALE; HUMANS; KIDNEY DISEASES; MALE; STROKE;

EID: 84885664177     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.04.072     Document Type: Article

References (9)

1. Y. Guo, H. Wang, and X. Zhao Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation Int J Cardiol 168 2013 1502 1508
2. J.P. Piccini, S.R. Stevens, and Y. Chang Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts Circulation 127 2 2013 224 232
3. S.H. Hohnloser, Z. Hijazi, and L. Thomas Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial Eur Heart J 33 2012 2821 2830
4. O.F. Laterza, C.P. Price, and M.G. Scott Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 48 2002 699 707
5. R. Providência, A. Fernandes, and L. Paiva Decreased glomerular filtration rate and markers of left atrial stasis in patients with nonvalvular atrial fibrillation Cardiology 124 1 2013 3 10
6. 2-VASc Score of 0 or 1?" Stroke 44 4 2013 e38
7. L. Friberg, L. Benson, M. Rosenqvist, and G.Y. Lip Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study BMJ 344 2012 e3522
8. 2-VASc score of 0 or 1? Stroke 43 10 2012 2551 2555
9. Editors of the Heart Group Journals Statement on matching language to the type of evidence used in describing outcomes data Int J Cardiol 166 2013 1